| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.056 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |